The India Custom Antibody Market was valued at $15.7 Million in 2024 and projected to reach to $26.1 Million by 2029, representing a compound annual growth rate of 10.7%. India's custom antibody market is positioned for significant expansion, driven by the country's emerging role as a global biopharmaceutical hub and increasing domestic R&D capabilities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India's custom antibody market is growing at 10.7% CAGR from 2024-2029, outpacing the global average of 9.2%, indicating accelerating market momentum and increasing adoption.
India's growing biotech ecosystem, supported by government initiatives and private sector investments, is creating a robust foundation for custom antibody development and manufacturing capabilities.
Increased pharmaceutical R&D spending across Indian companies and CROs is driving demand for custom antibodies in therapeutic development and diagnostic applications.
Growing demand for personalized therapeutics and targeted treatments in India is fueling the need for custom antibodies in precision medicine and immunotherapy research.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | ONCOLOGY (Indication) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.2% from 2024 to 2029 |
| Largest Segment | RESEARCH (Application) |
| Market Size Base Year (Billions) | ~USD 0.58 (2024) |
| Revenue Forecast (Billions) | ~USD 0.9 (2029) |
| Segments Covered | Service, Type, Source, Application, Indication, End User |
6 segment dimensions are covered across the global market.
India's custom antibody market was valued at $15.7 million in 2024 and is expected to grow to $26.1 million by 2029.
India's custom antibody market is projected to grow at a compound annual growth rate (CAGR) of 10.7% from 2024 to 2029.
India offers cost-effective manufacturing, a large pool of skilled researchers, strong pharmaceutical infrastructure, and increasing collaborations with international companies, making it an attractive destination for custom antibody development.
Demand for custom antibodies in India is driven by therapeutic development, diagnostic applications, academic research, and the growing adoption of personalized medicine approaches.
Primary consumers of custom antibodies in India include pharmaceutical companies, contract research organizations, academic institutions, and diagnostic laboratories engaged in drug discovery and development.
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information to analyze the global custom antibody market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the custom antibody market. The secondary sources used for this study include Antibody Society, Antibody Therapeutics, Pharmaceutical Research and Manufacturers of America (PhRMA), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), American Medical Association (AMA), Association of Medical Laboratory Immunologists (AMLI), Central Drugs Standard Control Organisation (CDSCO), Center for Drug Evaluation and Research (CDER), Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), World Health Organization (WHO), United States Food & Drug Administration (USFDA), Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Extensive primary research was conducted after acquiring basic knowledge about the global custom antibody market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from pharmaceutical & and biotechnology companies, academic & research institutes, and contract research organizations) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the custom antibody market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Custom antibody services include the production of antibodies from a wide variety of host species, depending on the desired outcome of the research study. These services range from antigen preparation, immunization, hybridoma production, and antibody characterization to production, purification, and labeling. The report includes the market size and forecast for the services used for custom antibody development, production, purification, and labeling.
The study provides an in-depth analysis of the custom antibody market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key custom antibody service providers
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Custom Antibody Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report